- Home
- FSI vs IMA Comparison
FSI vs IMA Comparison
Compare FSI & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FSI | IMA |
|---|---|---|
| Founded | 1991 | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.1M | 65.4M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | FSI | IMA |
|---|---|---|
| Price | $5.31 | $6.64 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 34.2K | ★ 46.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.89% | N/A |
| EPS Growth | ★ 9.09 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $15,494,325.00 | N/A |
| Revenue This Year | $4.11 | N/A |
| Revenue Next Year | $58.09 | N/A |
| P/E Ratio | $59.56 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.46 | $5.70 |
| 52 Week High | $11.48 | $17.50 |
Technical Indicators
Market Signals| Indicator | FSI | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 35.97 | 47.21 |
| Support Level | $5.13 | $6.65 |
| Resistance Level | $6.08 | $7.14 |
| Average True Range (ATR) | 0.23 | 0.44 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 12.72 | 20.19 |
Price Performance
Historical ComparisonAbout FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.